Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Paul Baker currently holds 78,184 shares of FIVE PRIME THERAPEUTICS INC (FPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Paul Baker has been a net neutral trader of FPRX stock. They have purchased $0 and sold $0 worth of shares.
Kevin Paul Baker's most recent insider trade was on Feb 26, 2018, when they sold 3,500 shares at $0.00 per share.
Kevin Paul Baker serves as Executive at FIVE PRIME THERAPEUTICS INC (FPRX). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Kevin Paul Baker holds the position of Executive at FIVE PRIME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Kevin Paul Baker has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Kevin Paul Baker was on Feb 1, 2018, when they sold $372.2K worth of FPRX shares. This transaction involved 18,866 shares at $19.73 per share.
Kevin Paul Baker currently owns 78,184 shares of FIVE PRIME THERAPEUTICS INC (FPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Paul Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Paul Baker has 6 Form 4 filings on record as an insider at FIVE PRIME THERAPEUTICS INC.
Set alerts for Kevin Paul Baker and 40,000+ other insiders.